| Year |
Citation |
Score |
| 2021 |
Belmontes B, Sawant DV, Zhong W, Tan H, Kaul A, Aeffner F, O'Brien SA, Chun M, Noubade R, Eng J, Ma H, Muenz M, Li P, Alba BM, Thomas M, ... ... Egen JG, et al. Immunotherapy combinations overcome resistance to bispecific T cell engager treatment in T cell-cold solid tumors. Science Translational Medicine. 13. PMID 34433637 DOI: 10.1126/scitranslmed.abd1524 |
0.509 |
|
| 2020 |
Zhang L, Li Z, Skrzypczynska KM, Fang Q, Zhang W, O'Brien SA, He Y, Wang L, Zhang Q, Kim A, Gao R, Orf J, Wang T, Sawant D, Kang J, ... ... Egen JG, et al. Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer. Cell. 181: 442-459.e29. PMID 32302573 DOI: 10.1016/J.Cell.2020.03.048 |
0.34 |
|
| 2020 |
Belmontes B, Tan H, Zhong W, Chui D, Cook K, O'Brien S, Martin M, Alexander B, Eng J, Harrold J, Aeffner F, Chun M, Bakker A, Balazs M, DeVoss J, ... ... Egen J, et al. Abstract PR12: Assessing in vivo mechanisms regulating the therapeutic activity of bi-specific T-cell engager (BiTE®) molecules in immunocompetent mice expressing a chimeric human/mouse CD3ε receptor Cancer Immunology Research. 8. DOI: 10.1158/2326-6074.Tumimm18-Pr12 |
0.455 |
|
| 2019 |
Kim A, Han CJ, Driver I, Olow A, Sewell AK, Zhang Z, Ouyang W, Egen JG, Yu X. Correction: LILRB1 Blockade Enhances Bispecific T Cell Engager Antibody-Induced Tumor Cell Killing by Effector CD8 T Cells. Journal of Immunology (Baltimore, Md. : 1950). PMID 31471523 DOI: 10.4049/jimmunol.1900968 |
0.516 |
|
| 2019 |
Kim A, Han CJ, Driver I, Olow A, Sewell AK, Zhang Z, Ouyang W, Egen JG, Yu X. LILRB1 Blockade Enhances Bispecific T Cell Engager Antibody-Induced Tumor Cell Killing by Effector CD8 T Cells. Journal of Immunology (Baltimore, Md. : 1950). PMID 31253728 DOI: 10.4049/jimmunol.1801472 |
0.538 |
|
| 2017 |
Lamb CA, Mansfield JC, Tew GW, Gibbons D, Long AK, Irving P, Diehl L, Eastham-Anderson J, Price MB, O'Boyle G, Jones DEJ, O'Byrne S, Hayday A, Keir ME, Egen JG, et al. αEβ7 Integrin Identifies Subsets of Pro-Inflammatory Colonic CD4+ T Lymphocytes in Ulcerative Colitis. Journal of Crohn's & Colitis. 11: 610-620. PMID 28453768 DOI: 10.1093/Ecco-Jcc/Jjw189 |
0.319 |
|
| 2016 |
Lamb CA, Mansfield JC, Tew GW, Gibbons D, Long AK, Irving P, Diehl L, Eastham-Anderson J, Price MB, O'Boyle G, Jones DE, O'Byrne S, Hayday A, Keir ME, Egen JG, et al. αEβ7 integrin identifies subsets of pro-inflammatory colonic CD4+ T lymphocytes in ulcerative colitis. Journal of Crohn's & Colitis. PMID 27797919 DOI: 10.1093/ecco-jcc/jjw189 |
0.319 |
|
| 2015 |
Lafkas D, Shelton A, Chiu C, de Leon Boenig G, Chen Y, Stawicki SS, Siltanen C, Reichelt M, Zhou M, Wu X, Eastham-Anderson J, Moore H, Roose-Girma M, Chinn Y, Hang JQ, ... ... Egen J, et al. Therapeutic antibodies reveal Notch control of transdifferentiation in the adult lung. Nature. PMID 26580007 DOI: 10.1038/nature15715 |
0.362 |
|
| 2014 |
Honda T, Egen JG, Lämmermann T, Kastenmüller W, Torabi-Parizi P, Germain RN. Tuning of antigen sensitivity by T cell receptor-dependent negative feedback controls T cell effector function in inflamed tissues. Immunity. 40: 235-247. PMID 24440150 DOI: 10.1016/J.Immuni.2013.11.017 |
0.473 |
|
| 2014 |
Torabi-Parizi P, Vrisekoop N, Kastenmuller W, Gerner MY, Egen JG, Germain RN. Pathogen-related differences in the abundance of presented antigen are reflected in CD4+ T cell dynamic behavior and effector function in the lung. Journal of Immunology (Baltimore, Md. : 1950). 192: 1651-60. PMID 24431231 DOI: 10.4049/Jimmunol.1301743 |
0.429 |
|
| 2013 |
Talay O, Yan D, Brightbill HD, Straney EE, Zhou M, Ladi E, Lee WP, Egen JG, Austin CD, Xu M, Wu LC. Addendum: IgE+ memory B cells and plasma cells generated through a germinal-center pathway. Nature Immunology. 14: 1302-4. PMID 24240161 DOI: 10.1038/Ni.2770 |
0.329 |
|
| 2013 |
Kastenmüller W, Brandes M, Wang Z, Herz J, Egen JG, Germain RN. Peripheral prepositioning and local CXCL9 chemokine-mediated guidance orchestrate rapid memory CD8+ T cell responses in the lymph node. Immunity. 38: 502-13. PMID 23352234 DOI: 10.1016/J.Immuni.2012.11.012 |
0.364 |
|
| 2011 |
Egen JG, Rothfuchs AG, Feng CG, Horwitz MA, Sher A, Germain RN. Intravital imaging reveals limited antigen presentation and T cell effector function in mycobacterial granulomas. Immunity. 34: 807-19. PMID 21596592 DOI: 10.1016/J.Immuni.2011.03.022 |
0.497 |
|
| 2008 |
Egen JG, Rothfuchs AG, Feng CG, Winter N, Sher A, Germain RN. Macrophage and T cell dynamics during the development and disintegration of mycobacterial granulomas. Immunity. 28: 271-84. PMID 18261937 DOI: 10.1016/J.Immuni.2007.12.010 |
0.359 |
|
| 2006 |
Bajénoff M, Egen JG, Koo LY, Laugier JP, Brau F, Glaichenhaus N, Germain RN. Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity. 25: 989-1001. PMID 17112751 DOI: 10.1016/J.Immuni.2006.10.011 |
0.372 |
|
| 2006 |
Qi H, Egen JG, Huang AY, Germain RN. Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells. Science (New York, N.Y.). 312: 1672-6. PMID 16778060 DOI: 10.1126/Science.1125703 |
0.376 |
|
| 2004 |
Pentcheva-Hoang T, Egen JG, Wojnoonski K, Allison JP. B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse. Immunity. 21: 401-13. PMID 15357951 DOI: 10.1016/J.Immuni.2004.06.017 |
0.42 |
|
| 2002 |
Egen JG, Kuhns MS, Allison JP. CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nature Immunology. 3: 611-8. PMID 12087419 DOI: 10.1038/Ni0702-611 |
0.579 |
|
| 2002 |
Egen JG, Allison JP. Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. Immunity. 16: 23-35. PMID 11825563 DOI: 10.1016/S1074-7613(01)00259-X |
0.588 |
|
| 2001 |
Chambers CA, Kuhns MS, Egen JG, Allison JP. CTLA-4-mediated inhibition in regulation of T cell responses: Mechanisms and manipulation in tumor immunotherapy Annual Review of Immunology. 19: 565-594. PMID 11244047 DOI: 10.1146/Annurev.Immunol.19.1.565 |
0.567 |
|
| Show low-probability matches. |